Five Prime Therapeutics reported $-21473000 in EBIT for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Amgen AMGN:US $ 2378M 45M
Astrazeneca AZN:US -4000000 1.45B
AstraZeneca AZN:LN -4000000 1.45B
Bristol Myers Squibb BMY:US $ 2985M 18M
Clovis Oncology CLVS:US $ -54192000 1.19M
Cytokinetics CYTK:US $ -69201000 14.4M
Daiichi Sankyo 4568:JP 38.97B 6.8B
Eli Lilly And LLY:US $ 2055.2M 626.8M
Glaxosmithkline GSK:US 2.67B 712M
GlaxoSmithKline GSK:LN 2.67B 712M
Halozyme Therapeutics HALO:US $ 75.59M 17.46M
Immunogen IMGN:US $ -34234000 6.86M
IONIS PHARMACEUT IONS:US $ -85849000 12.88M
Ironwood Pharmaceuticals IRWD:US $ 65.1M 282K
Johnson & Johnson JNJ:US $ 7033M 2723M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Macrogenics MGNX:US $ -52987000 12.71M
Merk MRK:US $ 5352M 3083M
Novartis NOVN:VX 3.48B 77M
Novartis NVS:US 3.48B 77M
Pfizer PFE:US $ 9254M 2592M
Sangamo Biosciences SGMO:US $ -48436000 264K
Xencor XNCR:US $ -41300000 50.39M